Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
Posted
Duncan Riley (via SiliconANGLE)
Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S. to supply biotech and pharmaceutical companies with the molecules their […]
Emerging Tech,
NEWS,
The-Latest,
AI,
artificial intelligence,
BIOSECURE Act,
Biotech,
Biotechnology Innovation Organization,
Brian Armstrong,
chemistry,
Coinbase,
Coinbase Global,
contract research,
Devoted Health,
DJ Patil,
Donald Trump,
drug discovery,
funding,
Institutional Venture Partners,
Kevin Weil,
Lightspeed Venture Partners,
Lux Capital Management,
Mano Paluri,
Menlo Ventures,
Meta platforms,
Meta Superintelligence Labs,
OpenAI,
pharmaceuticals,
robotics,
Sarah Friar,
Sol Reisberg,
Terremoto Biosciences,
Warp Sciences,
White House
